Tingrong Huang
Overview
Explore the profile of Tingrong Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
346
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shi L, Zheng Y, Cheng Z, Ji N, Niu C, Wang Y, et al.
Stem Cell Res Ther
. 2022 Jul;
13(1):321.
PMID: 35842684
Background: The novel coronavirus is still mutating, and the pandemic continues. Meanwhile, many COVID-19 survivors have residual postinfection clinical manifestations. Human umbilical cord mesenchymal stem cells (hUC-MSCs) have been shown...
2.
Chen Y, Xie J, Wu W, Li S, Hu Y, Hu M, et al.
Front Immunol
. 2022 Feb;
12:738532.
PMID: 35154067
Background: The benefits of intravenous immunoglobulin administration are controversial for critically ill COVID-19 patients. Methods: We analyzed retrospectively the effects of immunoglobulin administration for critically ill COVID-19 patients. The primary...
3.
Wu X, Zhou S, Liu C, Huang T, Zheng Y, Zhang W, et al.
Medicine (Baltimore)
. 2021 Oct;
100(40):e27410.
PMID: 34622847
The results of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid as one of the criteria has been widely applied to assess whether the coronavirus disease 2019 (COVID-19) patients...
4.
Zhang W, Xie Q, Xu X, Sun S, Fan T, Wu X, et al.
Trials
. 2021 Jul;
22(1):476.
PMID: 34294144
Background: Currently, coronavirus disease-2019 (COVID-19) is continuously and rapidly circulating, resulting in serious and extensive effects on human health. Due to the absence of antiviral medicine for COVID-19 thus far,...
5.
Zhou S, Feng J, Xie Q, Huang T, Xu X, Zhou D, et al.
Phytomedicine
. 2021 Jun;
89:153612.
PMID: 34126419
Background: Coronavirus disease 2019 (COVID-19) is still a pandemic, with a high mortality rate in severe/critical cases. Therapies based on the Shenghuang Granule have proved helpful in viral infection and...
6.
Feng G, Shi L, Huang T, Ji N, Zheng Y, Lin H, et al.
Stem Cells Dev
. 2021 May;
30(15):773-781.
PMID: 34044609
Previously, we demonstrated the therapeutic effects of human umbilical cord mesenchymal stromal cells (hUC-MSCs) in severe coronavirus disease 2019 (COVID-19) patients. In this 3-month follow-up study, we examined discharged patients...
7.
Xie J, Wu W, Li S, Hu Y, Hu M, Li J, et al.
Intensive Care Med
. 2020 Aug;
46(10):1863-1872.
PMID: 32816098
Purpose: An ongoing outbreak of coronavirus disease 2019 (COVID-19) emerged in Wuhan since December 2019 and spread globally. However, information about critically ill patients with COVID-19 is still limited. We...
8.
Shu L, Niu C, Li R, Huang T, Wang Y, Huang M, et al.
Stem Cell Res Ther
. 2020 Aug;
11(1):361.
PMID: 32811531
Background: COVID-19 is a highly infectious respiratory disease. No therapeutics have yet been proven effective for treating severe COVID-19. Objectives: To determine whether human umbilical cord mesenchymal stem cell infusion...
9.
Fang B, Zhang W, Wu X, Huang T, Li H, Zheng Y, et al.
Trials
. 2020 Jun;
21(1):568.
PMID: 32580752
Background: Currently, coronavirus disease 2019 (COVID-19) is continuously and rapidly circulating, causing heavy damage on public health. No effective antiviral treatment has been proved thus far. Traditional Chinese medicine (TCM)...
10.
Wu W, Huang T, Xiang F
Food Sci Nutr
. 2019 Nov;
7(11):3452-3462.
PMID: 31741734
In this paper, polyethylene glycol (PEG)-based ultrasonic-assisted enzymatic extraction (UAEE) was employed in polysaccharides extraction from leaves (LJLP). The optimal extraction conditions (extraction time of 33 min, PEG concentration of...